Top News

Jan 22, 2018
By Pharmaceutical Technology Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By Pharmaceutical Technology Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 10, 2018
Will Alex Azar’s experience in the pharmaceutical industry help or hurt the initiative to keep medications affordable?
Jan 09, 2018
By Pharmaceutical Technology Editors
The company announced 15 new collaborations focused on addressing unmet medical needs, including using artificial intelligence in the early detection of Alzheimer’s disease, saliva testing for throat cancers, and using the microbiome to treat sleep disorders.
Jan 05, 2018
By Pharmaceutical Technology Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Dec 20, 2017
New tax legislation may result in savings for biopharma companies.
Dec 18, 2017
By Pharmaceutical Technology Editors
The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.
Dec 05, 2017
By Pharmaceutical Technology Editors
Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.
Nov 21, 2017
By Pharmaceutical Technology Editors
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
Nov 14, 2017
By Pharmaceutical Technology Editors
The agency approved Abilify MyCite, a pill with a sensor that digitally tracks if patients have ingested their medication.
native1_300x100
lorem ipsum